Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model. (Q48238878)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

title

Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Daniel Zips

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Mariola Fotin-Mleczek

4

object named as

Mariola Fotin-Mleczek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

3

Regina Heidenreich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

author name string

Aleksandra Kowalczyk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Savas Tsitsekidis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Franziska Eckert

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Stephan M Huber

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

publication date

16 January 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

9 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

page(s)

653-662

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

The war on cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Emerging Opportunities and Challenges in Cancer Immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Tumour escape from immune surveillance through dendritic cell inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Cancer immunotherapy by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Regulatory T cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

The multiple personalities of the chemokine receptor CCR7 in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

How does radiation kill cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Effect of radiation on the expression of carcinoembryonic antigen of human gastric adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Ionizing radiation induces CD20 surface expression on human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Playing with nanoparticle shapes and laser powers to decide which route to take during photothermal therapy: apoptosis or necrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Immunologic correlates of the abscopal effect in a patient with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Abscopal effects of radiation therapy: a clinical review for the radiobiologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Protein expression from exogenous mRNA: uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Combining radiotherapy and cancer immunotherapy: a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

mRNA-based vaccines synergize with radiation therapy to eradicate established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Influence of tumor size and surgical resection on cell-mediated immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Impact of tumour volume on the potential efficacy of therapeutic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Biological effects of low-dose radiation from computed tomography scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Cancer immunotherapy: how low-level ionizing radiation can play a key role

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Beyond checkpoint inhibition - Immunotherapeutical strategies in combination with radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

The many roles of chemokines and chemokine receptors in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Barriers to Radiation-Induced In Situ Tumor Vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Ionizing radiation induces a motile phenotype in human carcinoma cells in vitro through hyperactivation of the TGF-beta signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Can immunostimulatory agents enhance the abscopal effect of radiotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

T-cell responses to survivin in cancer patients undergoing radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Standard treatments induce antigen-specific immune responses in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

The future of cancer treatment: immunomodulation, CARs and combination immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Cancer immunotherapy: the beginning of the end of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

New treatments in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

RNA-Based Vaccines in Cancer Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Can local radiotherapy and IL-12 synergise to overcome the immunosuppressive tumor microenvironment and allow "in situ tumor vaccination"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Maximizing tumor immunity with fractionated radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Contribution of the immune system to bystander and non-targeted effects of ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

Of mice and not men: differences between mouse and human immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-018-2117-0

10.1007/S00262-018-2117-0

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29335856%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference